Anne Freimoser-Grundschober

This inventor holds 24 USPTO granted patents and 21 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Bispecific Antibodies. Top assignees: Roche Glycart Ag, Hoffmann-La Roche Inc., Engmab Sarl. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Freimoser-Grundschober. Retrieved from https://idiyas.com/inventor/anne-freimoser-grundschober

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 21)

% Patents Active = 83.3

CIPO Patents = 4 (Patent Applications = 17)

EPO Patents = 4 (Patent Applications = 23)

Average Co-Inventor Count = 8.6

ph-index = 7

Forward Citations = 247(Granted Patents)

Location History:

Zürich, CH (2018)
Schlieren, CH (2021 - 2023)
Zurich, CH (2015 - 2024)

Company Filing History:

Hoffmann-La Roche Inc.

Bristol-Myers Squibb Compnay

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibody

CD3 Binding

T Cell Activation

Anti-FAP Antibodies

Interleukin-2 Polypeptides

Monoclonal Antibodies

BCMA Targeting

ROR1

TYRP-1

Fucosylated Antibodies

Tenascin-C

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473373 - BISPECIFIC ANTIBODY MOLECULES BINDING TO CD3 AND EGFRvIII (2025-11-18),

2. 12286486 - Anti-FAP antibodies and methods of use (2025-04-29),

3. 12215155 - Antibodies binding to CD3 and CD19 (2025-02-04),

4. 12139553 - T cell activating bispecific antigen binding molecules (2024-11-12),

5. 11952421 - Bispecific antibodies against CD3EPSILON and ROR1 (2024-04-09),

6. 11780920 - Antibodies binding to CD3 and CD19 (2023-10-10),

7. 11672858 - Bispecific antibody molecules binding to CD3 and TYRP-1 (2023-06-13),

8. 11591397 - Bispecific antibody molecules binding to CD3 and EGFRvIII (2023-02-28),

9. 11332545 - Anti-FAP antibodies and methods of use (2022-05-17),

10. 11111312 - Mutant interleukin-2 polypeptides (2021-09-07),

11. 10882918 - Bispecific T cell activating antigen binding molecules (2021-01-05),

12. 10851171 - Method for the selection of antibodies against BCMA (2020-12-01),

13. 10683369 - Monoclonal antibodies against BCMA (2020-06-16),

14. 10577429 - Anti-FAP antibodies and methods of use (2020-03-03),

15. 10323098 - Mutant interleukin-2 polypeptides (2019-06-18),

Title: Anne Freimoser-Grundschober: Pioneering Inventor from Zurich

Introduction: Anne Freimoser-Grundschober is a renowned inventor hailing from Zurich, Switzerland, known for her groundbreaking contributions to various fields of innovation.

Latest Patents: Anne Freimoser-Grundschober holds several patents in the areas of sustainable energy solutions, advanced medical devices, and cutting-edge technology applications.

Career Highlights: With a career spanning over two decades, Anne Freimoser-Grundschober has worked with leading research institutions and multinational companies to develop innovative solutions that have revolutionized industries worldwide.

Collaborations: Throughout her career, Anne Freimoser-Grundschober has collaborated with top scientists, engineers, and experts in diverse fields, fostering a culture of creativity and excellence in all her projects.

Conclusion: Anne Freimoser-Grundschober's passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology and science.

Profile summary based on public USPTO records.